N

NewGLab Pharma Co Ltd
KOSDAQ:214870

Watchlist Manager
NewGLab Pharma Co Ltd
KOSDAQ:214870
Watchlist
Price: 6 915 KRW -27.44%
Market Cap: 323.6B KRW
Have any thoughts about
NewGLab Pharma Co Ltd?
Write Note

NewGLab Pharma Co Ltd
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

NewGLab Pharma Co Ltd
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
N
NewGLab Pharma Co Ltd
KOSDAQ:214870
Capital Expenditures
-â‚©534.9m
CAGR 3-Years
37%
CAGR 5-Years
39%
CAGR 10-Years
N/A
V
Vidente Co Ltd
KOSDAQ:121800
Capital Expenditures
-â‚©17B
CAGR 3-Years
-623%
CAGR 5-Years
-59%
CAGR 10-Years
-20%
T
Tovis Co Ltd
KOSDAQ:051360
Capital Expenditures
-â‚©28.8B
CAGR 3-Years
-20%
CAGR 5-Years
-37%
CAGR 10-Years
-13%
F
Furonteer Co Ltd
KOSDAQ:370090
Capital Expenditures
-â‚©1.4B
CAGR 3-Years
-32%
CAGR 5-Years
-50%
CAGR 10-Years
N/A
P
Park Systems Corp
KOSDAQ:140860
Capital Expenditures
-â‚©25B
CAGR 3-Years
-18%
CAGR 5-Years
-81%
CAGR 10-Years
N/A
W
Woori Technology Inc
KOSDAQ:032820
Capital Expenditures
-â‚©30.3B
CAGR 3-Years
-176%
CAGR 5-Years
-67%
CAGR 10-Years
-32%
No Stocks Found

NewGLab Pharma Co Ltd
Glance View

Market Cap
323.6B KRW
Industry
Electrical Equipment

NewGLAB Pharma Co., Ltd. engages in the manufacture of closed-circuit television camera and equipment. The company is headquartered in Bucheon, Gyeonggi-Do. The company went IPO on 2015-10-13. The firm's product portfolio consists of general analog cameras that used for CCTVs, high definition (HD) analog cameras, HD-serial digital interface (SDI) cameras, extend (EX)-SDI cameras, internet protocol (IP) cameras that used for network CCTVs, digital video recorders (DVRs) that used for image storage devices, network video recorders (NVRs) and others. In addition, the Company is involved in the business of 5G smartphone distribution. The firm distributes its products within domestic market and to overseas markets.

Intrinsic Value
84.39 KRW
Overvaluation 99%
Intrinsic Value
Price
N

See Also

What is NewGLab Pharma Co Ltd's Capital Expenditures?
Capital Expenditures
-534.9m KRW

Based on the financial report for Sep 30, 2024, NewGLab Pharma Co Ltd's Capital Expenditures amounts to -534.9m KRW.

What is NewGLab Pharma Co Ltd's Capital Expenditures growth rate?
Capital Expenditures CAGR 5Y
39%

Over the last year, the Capital Expenditures growth was 6%. The average annual Capital Expenditures growth rates for NewGLab Pharma Co Ltd have been 37% over the past three years , 39% over the past five years .

Back to Top